The Clinical Research Grant supports innovative haemostatic research in rare bleeding disorders on non-interventional observational studies, focusing on patient outcomes, quality of life and social impact.
The maximum grant for up to one year is € 70,000.
Areas of interest include, but are not limited to:
In order to maintain a focus on the treatment of haemophilia and other rare bleeding disorders, Access to Insight clinical research grants will not support research focused on:
Applicants should be health care professionals providing care for haemophilia and rare bleeding disorders patients, including nurses, physiotherapists, and psychologists.
It is assumed that a maximum of 20% of the total grant can be assigned to the candidate’s institute as overhead costs.
The quality of the project idea is the main criterion for the proposal evaluation. Applications from previous grant recipients will not be considered until a period of at least two years has passed from receiving previous grant funding.
The conditions of the Access to Insight programme require that any additional funding for the same project from other sources (e.g. WFH, ISTH-SSC) be declared to both funding sources. We appreciate grant recipients’ cooperation in this regard.
Download or upload your application form here.
Please click here for more information about the application review process.
December 1st, 2025
Open for Applications
April 1st, 2025
Application Deadline
April-May 2025
Review and Selection
July 2025
Notification of recipient
September 2025
Funding Available
Services
Newsletter
The Haemophilia Academy is an independently run training programme led by a distinguished faculty of haemophilia experts.
More